Medicinal Cannabis Producer Bedrocan Is Returning to Canada
Medicinal Cannabis Producer Bedrocan Is Returning to Canada
VEENDAM, Netherlands, Oct. 10, 2024 /PRNewswire/ -- Bedrocan International, the world's most experienced producer of pharmaceutical-grade medicinal cannabis, is returning to the Canadian medicinal cannabis market. The company purchased a facility in Scarborough, the former home of Bedrocan in Canada, and was recently granted a cultivation license by Health Canada. These steps fulfil Bedrocan's long-held promise of returning to Canada to grow standardised medicinal cannabis for Canadian patients. The company intends to start production in early 2025.
VEENDAm,荷兰,2024年10月10日 / PRNewswire / -- Bedrocan International,全球经验最丰富的药品级医用大麻生产商,即将重返加拿大医用大麻市场。该公司收购了位于斯卡伯勒的设施,这是Bedrocan在加拿大的前总部,并最近获得了加拿大卫生部的种植许可证。这些步骤实现了Bedrocan长期以来重返加拿大为加拿大患者种植标准化医用大麻的承诺。该公司计划在2025年初开始生产。
Bedrocan is solely focused on producing medicinal cannabis and is known for its high-quality cannabis products with consistent levels of THC and CBD. Bedrocan's CEO Jaap Erkelens on Bedrocan's attention to patients: "We have had a strictly pharmaceutical approach since our foundation in 2003. We use the knowledge we have acquired in more than twenty years of business to produce cannabis products that benefit patients exclusively. In the same vein as prescribing physicians, patients want a reliable, standardised product with the same therapeutic effect time after time."
Bedrocan专注于生产医用大麻,以生产一贯的THC和CBD含量高品质大麻产品而闻名。Bedrocan首席执行官Jaap Erkelens关于Bedrocan对患者的关注:“自2003年成立以来,我们一直秉持严格的药品制度。我们利用我们在二十多年业务中所获得的知识,生产专门造福患者的大麻产品。患者和开处方的医生一样,希望得到具有相同疗效的可靠、标准化产品。”
The intention is for Bedrocan to bring several standardised cannabis products to the Canadian market of which the Bedrocan product is the most well-known. The cannabis products will be distributed through a third party via the medical sales channel to registered patients.
Bedrocan打算将几种标准化的大麻产品引入加拿大市场,其中Bedrocan产品最为知名。这些大麻产品将通过第三方经由医疗销售渠道分发给注册患者。
Bedrocan was previously active in Canada but ceased its activities after a partnership with Canopy Growth was terminated. Bedrocan has always expressed its intention to return to Canada one day. "We are thrilled to be coming back to Canada," said Erkelens. "We look forward to serving patients in Canada and positively impacting the Canadian healthcare landscape."
Bedrocan以前曾在加拿大活跃,但在与Canopy Growth的合作关系终止后停止了活动。Bedrocan一直表达了重返加拿大的意愿。Erkelens表示:“我们很高兴再次回到加拿大。我们期待为加拿大的患者提供服务,并对加拿大的医疗健康格局产生积极影响。”
SOURCE Bedrocan
资讯来源Bedrocan